Tyra Biosciences (TYRA) Other Non-Current Liabilities (2020 - 2024)

Quarterly Other Non-Current Liabilities fell 93.48% to $3000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3000.0 through Dec 2024, down 93.48% year-over-year, with the annual reading at $3000.0 for FY2024, 93.48% down from the prior year.

Tyra Biosciences filings provide 5 years of Other Non-Current Liabilities readings, the most recent being $3000.0 for Q4 2024.

  • Other Non-Current Liabilities hit $3000.0 in Q4 2024 for Tyra Biosciences, down from $11000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $434000.0 in Q3 2021 and bottomed at $3000.0 in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $155533.3, with a median of $139000.0 recorded in 2023.
  • The largest annual shift saw Other Non-Current Liabilities surged 162.14% in 2021 before it crashed 93.48% in 2024.
  • Tyra Biosciences' Other Non-Current Liabilities stood at $140000.0 in 2020, then surged by 162.14% to $367000.0 in 2021, then plummeted by 53.95% to $169000.0 in 2022, then crashed by 72.78% to $46000.0 in 2023, then crashed by 93.48% to $3000.0 in 2024.
  • Per Business Quant, the three most recent readings for TYRA's Other Non-Current Liabilities are $3000.0 (Q4 2024), $11000.0 (Q3 2024), and $20000.0 (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Tyra Biosciences 2.03 Bn 2.03 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 3,000.00
Sep 30, 2024 11,000.00
Jun 30, 2024 20,000.00
Mar 31, 2024 29,000.00
Dec 31, 2023 46,000.00
Sep 30, 2023 77,000.00
Jun 30, 2023 108,000.00
Mar 31, 2023 139,000.00
Dec 31, 2022 169,000.00
Sep 30, 2022 226,000.00
Jun 30, 2022 261,000.00
Mar 31, 2022 303,000.00
Dec 31, 2021 367,000.00
Sep 30, 2021 434,000.00
Dec 31, 2020 140,000.00